Yafei Biomedical Technology Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series B3

  • Latest Deal Amount
  • $41.8M

  • Investors
  • 20

Yafei Biomedical Technology General Information

Description

Developer of oncology drugs designed to address toxicity challenges in cancer treatment. The company's technology platform utilizes tumor microenvironment-activated linkers for selective drug delivery, providing antibody-drug conjugates, small-molecule conjugates, cytokine therapies, bispecific antibody conjugates, fusion protein therapies, and oncology drug candidates, enabling patients to receive targeted treatments with reduced systemic side effects.

Contact Information

Website
www.affinity.net.cn
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Block N, 4th Floor
  • Number 780 Cailun Road, China Pilot Free Trade Zone
  • Shanghai, 201203
  • China
+86 130
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Vertical(s)
LOHAS & Wellness, Life Sciences, Oncology
Corporate Office
  • Block N, 4th Floor
  • Number 780 Cailun Road, China Pilot Free Trade Zone
  • Shanghai, 201203
  • China
+86 130

Yafei Biomedical Technology Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Yafei Biomedical Technology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series B3) 27-Aug-2025 $41.8M Completed Generating Revenue
7. Later Stage VC (Series B2) 22-Nov-2024 Completed Generating Revenue
6. Later Stage VC 23-May-2024 Completed Generating Revenue
5. Later Stage VC (Series B1) 05-Jul-2023 Completed Generating Revenue
4. Later Stage VC (Series A1) 19-Jun-2022 Completed Generating Revenue
3. Later Stage VC 18-Nov-2021 Completed Generating Revenue
2. Later Stage VC (Series A) 05-Apr-2021 $8.72M Completed Generating Revenue
1. Later Stage VC 15-Jul-2019 $8.72M $8.72M Completed Generating Revenue
To view Yafei Biomedical Technology’s complete valuation and funding history, request access »

Yafei Biomedical Technology Investors (20)

Investor Name Investor Type Holding Investor Since Participating Rounds
Orchid Asia Group Management PE/Buyout Minority
Shanghai Zhijun Private Equity Fund Management Growth/Expansion Minority
Chengdu Bio-Town Investment Government Minority
China Growth Capital Venture Capital Minority
Guotong Chuangfeng Private Equity Fund Management Growth/Expansion Minority
You’re viewing 5 of 20 investors. Get the full list »

Ready to get started?

Request a free trial

Yafei Biomedical Technology Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Affinity (Drug Discovery) Shanghai, China 2011

Yafei Biomedical Technology FAQs

  • When was Yafei Biomedical Technology founded?

    Yafei Biomedical Technology was founded in 2012.

  • Where is Yafei Biomedical Technology headquartered?

    Yafei Biomedical Technology is headquartered in Shanghai, China.

  • What industry is Yafei Biomedical Technology in?

    Yafei Biomedical Technology’s primary industry is Drug Discovery.

  • Is Yafei Biomedical Technology a private or public company?

    Yafei Biomedical Technology is a Private company.

  • What is Yafei Biomedical Technology’s current revenue?

    The current revenue for Yafei Biomedical Technology is .

  • How much funding has Yafei Biomedical Technology raised over time?

    Yafei Biomedical Technology has raised $106M.

  • Who are Yafei Biomedical Technology’s investors?

    Orchid Asia Group Management, Shanghai Zhijun Private Equity Fund Management, Chengdu Bio-Town Investment, China Growth Capital, and Guotong Chuangfeng Private Equity Fund Management are 5 of 20 investors who have invested in Yafei Biomedical Technology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process